$PRVB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Provention Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Provention Bio, Inc.. Get notifications about new insider transactions in Provention Bio, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | PRVB | Provention Bio, In ... | Wysenski Nancy | Director | Option Exercise | A | 6.80 | 23,000 | 156,400 | 23,000 | |
| May 14 2021 | PRVB | Provention Bio, In ... | Pisano Wayne | Director | Option Exercise | A | 6.80 | 23,000 | 156,400 | 23,000 | |
| May 14 2021 | PRVB | Provention Bio, In ... | Jenkins John Kenneth | Director | Option Exercise | A | 6.80 | 23,000 | 156,400 | 23,000 | |
| May 14 2021 | PRVB | Provention Bio, In ... | Doherty Sean M | Director | Option Exercise | A | 6.80 | 23,000 | 156,400 | 23,000 | |
| May 14 2021 | PRVB | Provention Bio, In ... | Ramos Eleanor | Chief Medical Offic ... | Option Exercise | A | 6.80 | 139,500 | 948,600 | 139,500 | |
| May 14 2021 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Option Exercise | A | 6.80 | 23,000 | 156,400 | 23,000 | |
| May 14 2021 | PRVB | Provention Bio, In ... | Palmer Ashleigh | Director and CEO | Option Exercise | A | 6.80 | 139,500 | 948,600 | 139,500 | |
| May 14 2021 | PRVB | Provention Bio, In ... | Bluestone Jeffrey | Director | Option Exercise | A | 6.80 | 23,000 | 156,400 | 23,000 | |
| May 14 2021 | PRVB | Provention Bio, In ... | Leon Francisco | Chief Scientific Of ... | Option Exercise | A | 6.80 | 139,500 | 948,600 | 139,500 | |
| May 14 2021 | PRVB | Provention Bio, In ... | King-Jones Heidy | Chief Legal Officer | Option Exercise | A | 6.80 | 139,500 | 948,600 | 139,500 | |
| May 14 2021 | PRVB | Provention Bio, In ... | Hoitt Jason | Chief Commercial Of ... | Option Exercise | A | 6.80 | 139,500 | 948,600 | 139,500 | |
| May 14 2021 | PRVB | Provention Bio, In ... | Drechsler Andrew T | Chief Financial Off ... | Option Exercise | A | 6.80 | 139,500 | 948,600 | 139,500 | |
| Sep 02 2020 | PRVB | Provention Bio, In ... | Ramos Eleanor | Chief Medical Offic ... | Buy | P | 12.06 | 299 | 3,606 | 64,799 | 64.5 K to 64.8 K (+0.46 %) |
| Sep 02 2020 | PRVB | Provention Bio, In ... | Drechsler Andrew T | Chief Financial Off ... | Buy | P | 11.72 | 2,000 | 23,440 | 20,000 | 18 K to 20 K (+11.11 %) |
| Aug 21 2020 | PRVB | Provention Bio, In ... | Leon Francisco | Chief Scientific Of ... | Buy | P | 13.35 | 2,000 | 26,708 | 2,567,450 | 2.6 M to 2.6 M (+0.08 %) |
| Aug 20 2020 | PRVB | Provention Bio, In ... | Ramos Eleanor | Chief Medical Offic ... | Buy | P | 13.23 | 2,500 | 33,075 | 64,500 | 62 K to 64.5 K (+4.03 %) |
| Aug 18 2020 | PRVB | Provention Bio, In ... | Palmer Ashleigh | President and CEO | Buy | P | 12.69 | 500 | 6,345 | 2,566,300 | 2.6 M to 2.6 M (+0.02 %) |
| Aug 17 2020 | PRVB | Provention Bio, In ... | Palmer Ashleigh | President and CEO | Buy | P | 12.83 | 2,800 | 35,924 | 2,565,800 | 2.6 M to 2.6 M (+0.11 %) |
| Aug 13 2020 | PRVB | Provention Bio, In ... | Drechsler Andrew T | Chief Financial Off ... | Buy | P | 13.01 | 1,750 | 22,768 | 18,000 | 16.3 K to 18 K (+10.77 %) |
| Aug 11 2020 | PRVB | Provention Bio, In ... | Jenkins John Kenneth | Director | Option Exercise | A | 12.85 | 128,981 | 1,657,406 | 128,981 | |
| Aug 03 2020 | PRVB | Provention Bio, In ... | King-Jones Heidy | Chief Legal Officer | Option Exercise | A | 11.23 | 300,000 | 3,369,000 | 300,000 | |
| Jul 16 2020 | PRVB | Provention Bio, In ... | Pisano Wayne | Director | Option Exercise | A | 12.62 | 22,200 | 280,164 | 22,200 | |
| Jul 16 2020 | PRVB | Provention Bio, In ... | Ramos Eleanor | Chief Medical Offic ... | Option Exercise | A | 12.62 | 137,750 | 1,738,405 | 137,750 | |
| Jul 16 2020 | PRVB | Provention Bio, In ... | Hoitt Jason | Chief Commercial Of ... | Option Exercise | A | 12.62 | 137,750 | 1,738,405 | 137,750 | |
| Jul 16 2020 | PRVB | Provention Bio, In ... | Wysenski Nancy | Director | Option Exercise | A | 12.62 | 22,200 | 280,164 | 22,200 | |
| Jul 16 2020 | PRVB | Provention Bio, In ... | Doherty Sean M | Director | Option Exercise | A | 12.62 | 22,200 | 280,164 | 22,200 | |
| Jul 16 2020 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Option Exercise | A | 12.62 | 22,200 | 280,164 | 22,200 | |
| Jul 16 2020 | PRVB | Provention Bio, In ... | Leon Francisco | Chief Scientific Of ... | Option Exercise | A | 12.62 | 137,750 | 1,738,405 | 137,750 | |
| Jul 16 2020 | PRVB | Provention Bio, In ... | Bluestone Jeffrey | Director | Option Exercise | A | 12.62 | 22,200 | 280,164 | 22,200 | |
| Jul 16 2020 | PRVB | Provention Bio, In ... | Drechsler Andrew T | Chief Financial Off ... | Option Exercise | A | 12.62 | 137,750 | 1,738,405 | 137,750 | |
| Jul 16 2020 | PRVB | Provention Bio, In ... | Palmer Ashleigh | President and CEO | Option Exercise | A | 12.62 | 137,750 | 1,738,405 | 137,750 | |
| Jun 24 2020 | PRVB | Provention Bio, In ... | Leon Francisco | Chief Scientific Of ... | Buy | P | 15.43 | 2,000 | 30,862 | 2,565,450 | 2.6 M to 2.6 M (+0.08 %) |
| May 21 2020 | PRVB | Provention Bio, In ... | Wysenski Nancy | Director | Option Exercise | A | 13.16 | 128,981 | 1,697,390 | 128,981 | |
| Apr 14 2020 | PRVB | Provention Bio, In ... | Bluestone Jeffrey | Director | Option Exercise | G | 12.54 | 24,000 | 300,960 | 0 | |
| Apr 14 2020 | PRVB | Provention Bio, In ... | Bluestone Jeffrey | Director | Option Exercise | G | 12.54 | 24,000 | 300,960 | 0 | |
| Apr 14 2020 | PRVB | Provention Bio, In ... | Bluestone Jeffrey | Director | Option Exercise | M | 2.36 | 32,246 | 76,101 | 96,735 | |
| Apr 14 2020 | PRVB | Provention Bio, In ... | Bluestone Jeffrey | Director | Option Exercise | G | 2.36 | 128,981 | 304,395 | 0 | |
| Apr 14 2020 | PRVB | Provention Bio, In ... | Bluestone Jeffrey | Director | Option Exercise | G | 2.36 | 128,981 | 304,395 | 0 | |
| Apr 14 2020 | PRVB | Provention Bio, In ... | Bluestone Jeffrey | Director | Buy | M | 2.36 | 32,246 | 76,101 | 39,571 | 7.3 K to 39.6 K (+440.22 %) |
| Mar 20 2020 | PRVB | Provention Bio, In ... | Leon Francisco | Chief Scientific Of ... | Buy | P | 5.92 | 10,000 | 59,200 | 2,563,450 | 2.6 M to 2.6 M (+0.39 %) |
| Mar 20 2020 | PRVB | Provention Bio, In ... | Hoitt Jason | Chief Commercial Of ... | Buy | P | 5.43 | 4,500 | 24,435 | 4,500 | 0 to 4.5 K |
| Jan 08 2020 | PRVB | Provention Bio, In ... | Hoitt Jason | Chief Commercial Of ... | Option Exercise | A | 14.97 | 400,000 | 5,988,000 | 400,000 | |
| Dec 26 2019 | PRVB | Provention Bio, In ... | Ramos Eleanor | CMO & COO | Buy | P | 14.34 | 2,000 | 28,680 | 62,000 | 60 K to 62 K (+3.33 %) |
| Dec 23 2019 | PRVB | Provention Bio, In ... | Palmer Ashleigh | President and CEO | Buy | P | 11.39 | 2,075 | 23,634 | 2,563,000 | 2.6 M to 2.6 M (+0.08 %) |
| Dec 16 2019 | PRVB | Provention Bio, In ... | Leon Francisco | Chief Scientific Of ... | Buy | P | 11.92 | 2,000 | 23,840 | 2,553,450 | 2.6 M to 2.6 M (+0.08 %) |
| Dec 06 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | J | 0.00 | 342,000 | 0 | 520,712 | 178.7 K to 520.7 K (+191.37 %) |
| Sep 30 2019 | PRVB | Provention Bio, In ... | Leon Francisco | Chief Scientific Of ... | Buy | P | 7.67 | 1,450 | 11,122 | 2,551,450 | 2.6 M to 2.6 M (+0.06 %) |
| Sep 30 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 6.83 | 30,000 | 204,900 | 178,712 | 148.7 K to 178.7 K (+20.17 %) |
| Sep 30 2019 | PRVB | Provention Bio, In ... | Doherty Sean M | Director | Option Exercise | A | 8.33 | 128,981 | 1,074,412 | 128,981 | |
| Sep 26 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 8.44 | 5,000 | 42,200 | 148,712 | 143.7 K to 148.7 K (+3.48 %) |
| Sep 25 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 8.39 | 5,000 | 41,950 | 143,712 | 138.7 K to 143.7 K (+3.60 %) |
| Sep 24 2019 | PRVB | Provention Bio, In ... | Palmer Ashleigh | President and CEO | Buy | P | 8.38 | 3,000 | 25,140 | 2,560,925 | 2.6 M to 2.6 M (+0.12 %) |
| Aug 09 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 9.09 | 10,000 | 90,900 | 138,712 | 128.7 K to 138.7 K (+7.77 %) |
| Aug 09 2019 | PRVB | Provention Bio, In ... | Leon Francisco | Chief Scientific Of ... | Buy | P | 9.09 | 2,500 | 22,725 | 2,550,000 | 2.5 M to 2.6 M (+0.10 %) |
| Aug 09 2019 | PRVB | Provention Bio, In ... | Palmer Ashleigh | President and CEO | Buy | P | 9.15 | 10,600 | 96,990 | 2,557,925 | 2.5 M to 2.6 M (+0.42 %) |
| Jun 25 2019 | PRVB | Provention Bio, In ... | Ramos Eleanor | Chief Medical Offic ... | Option Exercise | A | 12.54 | 400,000 | 5,016,000 | 400,000 | |
| Jun 25 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 12.54 | 24,000 | 300,960 | 24,000 | |
| Jun 25 2019 | PRVB | Provention Bio, In ... | Drechsler Andrew T | Chief Financial Off ... | Option Exercise | A | 12.54 | 400,000 | 5,016,000 | 400,000 | |
| Jun 25 2019 | PRVB | Provention Bio, In ... | Palmer Ashleigh | President & CEO | Option Exercise | A | 12.54 | 400,000 | 5,016,000 | 400,000 | |
| Jun 25 2019 | PRVB | Provention Bio, In ... | Pisano Wayne | Director | Option Exercise | A | 12.54 | 24,000 | 300,960 | 24,000 | |
| Jun 25 2019 | PRVB | Provention Bio, In ... | Leon Francisco | Chief Scientific Of ... | Option Exercise | A | 12.54 | 400,000 | 5,016,000 | 400,000 | |
| Jun 25 2019 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Option Exercise | A | 12.54 | 24,000 | 300,960 | 24,000 | |
| Jun 25 2019 | PRVB | Provention Bio, In ... | Bluestone Jeffrey | Director | Option Exercise | A | 12.54 | 24,000 | 300,960 | 24,000 | |
| Jun 20 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 10.96 | 10,000 | 109,600 | 128,712 | 118.7 K to 128.7 K (+8.42 %) |
| Jun 18 2019 | PRVB | Provention Bio, In ... | Palmer Ashleigh | President and CEO | Buy | P | 10.83 | 4,000 | 43,320 | 2,547,325 | 2.5 M to 2.5 M (+0.16 %) |
| Jun 18 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 10.88 | 10,000 | 108,800 | 118,712 | 108.7 K to 118.7 K (+9.20 %) |
| Jun 17 2019 | PRVB | Provention Bio, In ... | Bluestone Jeffrey | Director | Sell | S | 11.93 | 7,300 | 87,089 | 7,325 | 14.6 K to 7.3 K (-49.91 %) |
| Jun 17 2019 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 12.16 | 25,000 | 304,000 | 108,712 | 83.7 K to 108.7 K (+29.86 %) |
| Mar 28 2019 | PRVB | Provention Bio, In ... | Bluestone Jeffrey | Director | Option Exercise | A | 2.36 | 128,981 | 304,395 | 128,981 | |
| Jan 02 2019 | PRVB | Provention Bio, In ... | Leon Francisco | Chief Scientific Of ... | Buy | P | 1.64 | 10,000 | 16,400 | 2,547,500 | 2.5 M to 2.5 M (+0.39 %) |
| Dec 31 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 1.76 | 10,000 | 17,600 | 83,712 | 73.7 K to 83.7 K (+13.57 %) |
| Dec 31 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 1.76 | 10,000 | 17,600 | 83,712 | 73.7 K to 83.7 K (+13.57 %) |
| Dec 31 2018 | PRVB | Provention Bio, In ... | Palmer Ashleigh | President and CEO | Buy | P | 1.58 | 825 | 1,304 | 2,543,325 | 2.5 M to 2.5 M (+0.03 %) |
| Dec 31 2018 | PRVB | Provention Bio, In ... | Palmer Ashleigh | President and CEO | Buy | P | 1.58 | 825 | 1,304 | 2,543,325 | 2.5 M to 2.5 M (+0.03 %) |
| Dec 31 2018 | PRVB | Provention Bio, In ... | Palmer Ashleigh | President and CEO | Buy | P | 1.73 | 5,000 | 8,650 | 2,542,500 | 2.5 M to 2.5 M (+0.20 %) |
| Dec 31 2018 | PRVB | Provention Bio, In ... | Palmer Ashleigh | President and CEO | Buy | P | 1.73 | 5,000 | 8,650 | 2,542,500 | 2.5 M to 2.5 M (+0.20 %) |
| Dec 31 2018 | PRVB | Provention Bio, In ... | Pisano Wayne | Director | Buy | P | 1.80 | 5,000 | 9,000 | 7,500 | 2.5 K to 7.5 K (+200.00 %) |
| Dec 31 2018 | PRVB | Provention Bio, In ... | Pisano Wayne | Director | Buy | P | 1.80 | 5,000 | 9,000 | 7,500 | 2.5 K to 7.5 K (+200.00 %) |
| Dec 28 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 1.95 | 20,000 | 39,000 | 73,712 | 53.7 K to 73.7 K (+37.24 %) |
| Dec 27 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 1.92 | 17,270 | 33,158 | 53,712 | 36.4 K to 53.7 K (+47.39 %) |
| Dec 27 2018 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Buy | P | 1.85 | 5,000 | 9,250 | 20,000 | 15 K to 20 K (+33.33 %) |
| Dec 27 2018 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Buy | P | 1.90 | 5,000 | 9,500 | 15,000 | 10 K to 15 K (+50.00 %) |
| Dec 26 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 1.85 | 2,000 | 3,700 | 36,442 | 34.4 K to 36.4 K (+5.81 %) |
| Dec 21 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 1.96 | 5,000 | 9,800 | 34,442 | 29.4 K to 34.4 K (+16.98 %) |
| Dec 06 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 2.45 | 4,442 | 10,883 | 29,442 | 25 K to 29.4 K (+17.77 %) |
| Dec 03 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 2.45 | 4,849 | 11,880 | 25,000 | 20.2 K to 25 K (+24.06 %) |
| Dec 03 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 2.47 | 151 | 373 | 20,151 | 20 K to 20.2 K (+0.76 %) |
| Nov 28 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 2.46 | 10,000 | 24,600 | 20,000 | 10 K to 20 K (+100.00 %) |
| Nov 27 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Buy | P | 2.65 | 10,000 | 26,500 | 10,000 | 0 to 10 K |
| Nov 13 2018 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Buy | P | 3.15 | 10,000 | 31,500 | 10,000 | 0 to 10 K |
| Sep 05 2018 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Option Exercise | A | 3.88 | 128,981 | 500,446 | 128,981 | |
| Jul 26 2018 | PRVB | Provention Bio, In ... | APPEL PETER A | 10% Owner | Buy | P | 4.00 | 750,000 | 3,000,000 | 1,950,000 | 1.2 M to 2 M (+62.50 %) |
| Jul 26 2018 | PRVB | Provention Bio, In ... | APPEL PETER A | 10% Owner | Buy | P | 4.00 | 750,000 | 3,000,000 | 1,950,000 | 1.2 M to 2 M (+62.50 %) |
| Jul 26 2018 | PRVB | Provention Bio, In ... | APPEL PETER A | 10% Owner | Buy | C | 0.00 | 1,200,000 | 0 | 1,200,000 | 0 to 1.2 M |
| Jul 26 2018 | PRVB | Provention Bio, In ... | APPEL PETER A | 10% Owner | Buy | C | 0.00 | 1,200,000 | 0 | 1,200,000 | 0 to 1.2 M |
| Jul 20 2018 | PRVB | Provention Bio, In ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 2,400,000 | 0 | 0 | |
| Jul 20 2018 | PRVB | Provention Bio, In ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 2,400,000 | 0 | 2,400,000 | 0 to 2.4 M |
| Jul 19 2018 | PRVB | Provention Bio, In ... | MDB CAPITAL GROUP LLC | 10% Owner | Option Exercise | J | 5.00 | 1,596,956 | 7,984,780 | 1,871,245 | |
| Jul 19 2018 | PRVB | Provention Bio, In ... | MDB CAPITAL GROUP LLC | 10% Owner | Option Exercise | C | 2.50 | 274,289 | 685,723 | 274,289 | |
| Jul 19 2018 | PRVB | Provention Bio, In ... | MDB CAPITAL GROUP LLC | 10% Owner | Option Exercise | C | 2.50 | 274,289 | 685,723 | 0 | |
| Jul 19 2018 | PRVB | Provention Bio, In ... | Pisano Wayne | Director | Option Exercise | A | 4.00 | 128,981 | 515,924 | 128,981 | |
| Jul 19 2018 | PRVB | Provention Bio, In ... | Pisano Wayne | Director | Buy | P | 4.00 | 2,500 | 10,000 | 2,500 | 0 to 2.5 K |
| Jul 19 2018 | PRVB | Provention Bio, In ... | Palmer Ashleigh | President and CEO | Buy | P | 4.00 | 37,500 | 150,000 | 2,537,500 | 2.5 M to 2.5 M (+1.50 %) |
| Jul 19 2018 | PRVB | Provention Bio, In ... | Leon Francisco | Chief Scientific Of ... | Buy | P | 4.00 | 37,500 | 150,000 | 2,537,500 | 2.5 M to 2.5 M (+1.50 %) |
| Jul 19 2018 | PRVB | Provention Bio, In ... | Gray Cameron | Director | Option Exercise | C | 2.50 | 144,824 | 362,060 | 144,824 | |
| Jul 19 2018 | PRVB | Provention Bio, In ... | Gray Cameron | Director | Option Exercise | A | 4.00 | 128,981 | 515,924 | 128,981 | |
| Jul 19 2018 | PRVB | Provention Bio, In ... | Drechsler Andrew T | Chief Financial Off ... | Buy | P | 4.00 | 6,250 | 25,000 | 6,250 | 0 to 6.3 K |
| Jul 19 2018 | PRVB | Provention Bio, In ... | Ramos Eleanor | Chief Medical Offic ... | Buy | P | 4.00 | 60,000 | 240,000 | 60,000 | 0 to 60 K |
| Jul 19 2018 | PRVB | Provention Bio, In ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 4.00 | 128,981 | 515,924 | 128,981 |
Page: 1